Chemical shift imaging of bone marrow: preliminary experience.
A phase-contrast method of chemical shift imaging was used to evaluate bone marrow in normal volunteers and in patients with metabolic, inflammatory, traumatic, and neoplastic disorders. Five normal volunteers were examined in order to obtain preliminary data on normal patterns of signal intensity in hematopoietic and fatty marrow using both conventional magnetic resonance imaging and proton chemical shift imaging. Normally, hematopoietic marrow yields low signal intensity on phase-contrast images; pathologic conditions affecting hematopoietic marrow typically result in increased signal intensity due to either accumulated lipid or water. Because of its high fat content, yellow marrow normally yields high signal intensity on phase-contrast images, whereas abnormal conditions usually result in decreased phase-contrast signal intensity due to increased tissue water. Proton chemical shift imaging is likely to be a valuable supplement to standard magnetic resonance imaging techniques in the study of bone marrow in vivo.
D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology* / Q000528:radiation effects; D002648:Child; D005260:Female; D005776:Gaucher Disease / Q000473:pathology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000473:pathology; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D008875:Middle Aged; D013978:Tibial Fractures / Q000473:pathology